These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8753053)

  • 1. [Present status and future of blood management in Japan].
    Sekiguchi S; Ikebuchi K
    Nihon Naika Gakkai Zasshi; 1996 Jun; 85(6):862-70. PubMed ID: 8753053
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion medicine 1994.
    Pineda A; Korbling M; Rock GA
    Rev Invest Clin; 1994 Apr; Suppl():101-15. PubMed ID: 7886293
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukocyte-reduced blood components in transfusion medicine. Current indications and prospects for the future.
    Klapper EB; Goldfinger D
    Clin Lab Med; 1992 Dec; 12(4):711-21. PubMed ID: 1286560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Basic problems of contemporary blood donation and blood therapy].
    Sabliński J
    Acta Haematol Pol; 1995; 26(2 Suppl 1):79-85. PubMed ID: 7653238
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transfusion medicine in near future].
    Sekiguchi S
    Rinsho Byori; 1992 Jun; 40(6):617-25. PubMed ID: 1513033
    [No Abstract]   [Full Text] [Related]  

  • 6. [Posttransfusion graft vs host disease].
    Muñoz MC; Hernández M; Rifón J; Panizo C; Rodríguez M
    Sangre (Barc); 1998 Feb; 43(1):55-8. PubMed ID: 9580428
    [No Abstract]   [Full Text] [Related]  

  • 7. [Management of pancytopenia blood component transfusion and recombinant growth factor].
    Watanabe K; Yonekura S; Komatsuda M; Yabe M
    Nihon Rinsho; 1990 Sep; 48(9):2035-40. PubMed ID: 2172589
    [No Abstract]   [Full Text] [Related]  

  • 8. [The new Blood Law and new principles of transfusion therapy].
    Takahashi K
    Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):3-6. PubMed ID: 15696691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Past, present, future use of blood substitutes and plasma substitutes in Japan].
    Toyama H
    Masui; 1985 Apr; 34(4):515-29. PubMed ID: 4021100
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood transfusion problems. Post-transfusional pathology. Proposal fo assessment].
    Utizi S; Barchiesi G; Albanesi A; Silvestri G; Silvestri G
    G Clin Med; 1989 Mar; 70(3):203-16. PubMed ID: 2668096
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
    Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of leukocyte-reduced blood components.
    Miller JP; Mintz PD
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):69-90. PubMed ID: 7737945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status and prospects for blood transfusion and products of blood components in the field of surgery].
    Tsurumaru M
    Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):2. PubMed ID: 15696690
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of post-transfusion graft-versus-host disease.
    Tasaki T; Ohto H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-associated graft-versus-host disease.
    Dwyre DM; Holland PV
    Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of transfusions caused by leukocytes.
    Raife TJ
    J Intraven Nurs; 1997; 20(5):238-44. PubMed ID: 9369624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan.
    Juji T; Takahashi K; Shibata Y; Ide H; Sakakibara T; Ino T; Mori S
    N Engl J Med; 1989 Jul; 321(1):56. PubMed ID: 2733750
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk reduction strategies in pediatric blood banking.
    Billman GF
    Pathology (Phila); 1993; 2(1):61-80. PubMed ID: 9420931
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transfusion: risks and future prospects].
    Molaro GL
    G Clin Med; 1990 Oct; 71(10):547-59. PubMed ID: 2289650
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
    Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.